Aclaris Therapeutics Reports Fourth Quarter and Full Year 2015 Operating and Financial Results

Go back to Aclaris Therapeutics Reports Fourth Quarter and Full Year 2015 Operating and Financial Results
(NASDAQ: ACRS) Delayed: 5.57 --0 (-0%)
Previous Close $5.57    52 Week High $33.88 
Open $5.57    52 Week Low $14.12 
Day High $5.57    P/E N/A 
Day Low $5.57    EPS $0.00 
Volume 394